Xylem Affirms Q3 Adj EPS Guidance of $1.42-$1.47 vs $1.46 Est; Affirms Q3 Sales Guidance of $2.300B vs $2.316B Est
Xylem (NYSE:XYL) affirms Q3 Adj EPS guidance from $1.42-$1.47 to $1.42-$1.47 vs $1.46 analyst estimate. Affirms Q3 sales outlook from $2.300 billion to $2.300 billion vs $2.316 billion estimate.
Xylem is sticking with its plan to earn between $1.42 and $1.47 per share this quarter, which is close to what experts guessed. The company also isn't changing its sales forecast, even though it might end up a tiny bit lower than some people expected.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.